ASB Stock Analysis: Associated Banc-Corp | NYSE
Banks - Regional | NYSE, USA | Market Cap: 5.412m USD | 12M Return: 13% | US0454871056 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 61.9M
EPS Trend: 76.9%
Qual. Beats: 0
Rev. Trend: 82.3%
Qual. Beats: 1
Warnings
Tailwinds
Seasonality 11.7 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Associated Banc-Corp (ASB) is a bank holding company headquartered in Green Bay, Wisconsin, that provides a full suite of banking and nonbanking services to individuals and businesses. Founded in 1861, the company operates primarily across the Midwest, with its core banking presence in Wisconsin, Illinois, Missouri, Texas, and Minnesota, and additional loan production offices in Indiana, Kansas, Michigan, New York, and Ohio.
Its offerings span commercial and consumer lending (including commercial real estate, construction, residential mortgages, home equity, auto finance, and asset-based lending), deposit and cash management solutions, specialized services such as interest rate risk management and foreign exchange, fiduciary and institutional asset management, and investable funds and brokerage products. The company also provides retail transactional services, including checking accounts, credit and debit cards, online banking, and money transfer services.
As a mid-cap regional bank, ASB generates revenue primarily through net interest income from lending activities and fee-based income from its wealth management, treasury management, and brokerage services. Bank holding companies of this type are regulated by the Federal Reserve and typically focus on relationship-based commercial and retail banking within their defined geographic footprint.
- Net interest margin compresses as Fed rate cuts pressure loan spreads
- Commercial real estate exposure raises credit loss provisions
- Deposit costs climb amid intense Midwest regional banking competition
| Net Income: 505.1m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.01 > 0.02 and ΔFCF/TA 0.16 > 1.0 |
| NWC/Revenue: 7.82% < 20% (prev -1.48k%; Δ 1.48k% < -1%) |
| CFO/TA 0.01 > 3% & CFO 719.0m > Net Income 505.1m |
| Net Debt (-1.22b) to EBITDA (731.7m): -1.67 < 3 |
| Current Ratio: 1.38 > 1.5 & < 3 |
| Outstanding Shares: last quarter (189.9m) vs 12m ago 14.16% < -2% |
| Gross Margin: 60.54% > 18% (prev 48.47%; Δ 12.07% > 0.5%) |
| Asset Turnover: 5.36% > 50% (prev 4.81%; Δ 0.55% > 0%) |
| Interest Coverage Ratio: 0.66 > 6 (EBIT TTM 629.2m / Interest Expense TTM 959.8m) |
| A: 0.00 (Total Current Assets 730.0m - Total Current Liabilities 529.3m) / Total Assets 51.8b |
| B: 0.07 (Retained Earnings 3.38b / Total Assets 51.8b) |
| C: 0.01 (EBIT TTM 629.2m / Avg Total Assets 47.9b) |
| D: 0.12 (Book Value of Equity 5.64b / Total Liabilities 46.2b) |
| Altman-Z'' = 0.45 = B |
| DSRI: 0.89 (Receivables 181.9m/168.6m, Revenue 2.57b/2.12b) |
| GMI: 0.80 (GM 48.47% / 60.54%) |
| AQI: 1.16 (AQ_t 0.98 / AQ_t-1 0.84) |
| SGI: 1.21 (Revenue 2.57b / 2.12b) |
| TATA: -0.00 (NI 505.1m - CFO 719.0m) / TA 51.8b) |
| Beneish M = -3.05 (Cap -4..+1) = AA |
As of October 06, 2026, the stock is trading at USD 29.02 with a total of 1,387,365 shares traded. Over the past week, the price has changed by +0.21%, over one month by -4.88%, over three months by -4.57% and over the past year by +12.97%.
Current recommended Stop Loss: 28.20 (which is 2.8% or 1.5 ATR below the current price).
Associated Banc-Corp has received a consensus analysts rating of 3.30. Therefore, it is recommended to hold ASB.
- StrongBuy: 1
- Buy: 1
- Hold: 8
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 34.4 | 18.5% |
P/E Trailing = 10.1343
P/E Forward = 9.1912
P/S = 3.4785
P/B = 1.0365
P/EG = 1.7796
Revenue TTM = 2.57b USD
EBIT TTM = 629.2m USD
EBITDA TTM = 731.7m USD
Long Term Debt = 850.8m USD (from longTermDebt, last quarter)
Short Term Debt = 529.3m USD (from shortTermDebt, last quarter)
Debt = 5.70b USD (from shortLongTermDebtTotal, last quarter) + Leases 228k
Net Debt = -1.22b USD (calculated: Debt 5.70b - CCE 6.91b)
Enterprise Value = 4.19b USD (5.41b + Debt 5.70b - CCE 6.91b)
Interest Coverage Ratio = 0.66 (Ebit TTM 629.2m / Interest Expense TTM 959.8m)
EV/FCF = 6.17x (Enterprise Value 4.19b / FCF TTM 679.6m)
FCF Yield = 16.21% (FCF TTM 679.6m / Enterprise Value 4.19b)
FCF Margin = 26.47% (FCF TTM 679.6m / Revenue TTM 2.57b)
Net Margin = 19.67% (Net Income TTM 505.1m / Revenue TTM 2.57b)
Gross Margin = 60.54% ((Revenue TTM 2.57b - Cost of Revenue TTM 1.01b) / Revenue TTM)
Gross Margin QoQ = 61.26% (prev 61.61%)
Tobins Q-Ratio = 0.08 (Enterprise Value 4.19b / Total Assets 51.8b)
Interest Expense / Debt = 16.85% (Interest Expense 959.8m / Debt 5.70b)
Taxrate = 19.73% (124.2m / 629.2m)
NOPAT = 505.1m (EBIT 629.2m * (1 - 19.73%))
Current Ratio = 1.38 (Total Current Assets 730.0m / Total Current Liabilities 529.3m)
Debt / Equity = 1.01 (Debt 5.70b / totalStockholderEquity, last quarter 5.64b)
Debt / EBITDA = -1.67 (Net Debt -1.22b / EBITDA 731.7m)
Debt / FCF = -1.79 (Net Debt -1.22b / FCF TTM 679.6m)
Total Stockholder Equity = 5.12b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.05% (Net Income 505.1m / Total Assets 51.8b)
RoE = 9.86% (Net Income TTM 505.1m / Total Stockholder Equity 5.12b)
RoCE = 10.54% (EBIT 629.2m / Capital Employed (Equity 5.12b + L.T.Debt 850.8m))
RoIC = 0.98% (NOPAT 505.1m / Invested Capital 51.7b)
WACC = 11.72% (E(5.41b)/V(11.1b) * Re(9.81%) + D(5.70b)/V(11.1b) * Rd(16.85%) * (1-Tc(0.20)))
Discount Rate = 9.81% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 87.82 | Cagr: 10.63%
[DCF] Terminal Value 67.88% ; FCFF base≈611.3m ; Y1≈700.8m ; Y5≈1.03b
[DCF] Fair Price = 57.92 (EV 9.71b - Net Debt -1.22b = Equity 10.9b / Shares 188.7m; r=11.72% [WACC]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 76.92 | EPS CAGR: 11.12% | SUE: 0.33 | # QB: 0
Revenue Correlation: 82.32 | Revenue CAGR: 7.53% | SUE: 0.91 | # QB: 1
EPS current Quarter (2026-09-30): EPS=0.75 | Chg30d=-0.09% | Revisions=-12% | Analysts=10
EPS current Year (2026-12-31): EPS=2.96 | Chg30d=+0.27% | Revisions=+0% | GrowthEPS=+5.1% | GrowthRev=+19.0%
EPS next Year (2027-12-31): EPS=3.34 | Chg30d=+0.14% | Revisions=+62% | GrowthEPS=+12.8% | GrowthRev=+8.5%
[Analyst] Revisions Ratio: +21% (up=10, down=6)